Ying Hao
- Biomedical Engineering top 1%
- Biomaterials top 1%
- Materials Chemistry top 5%
- Molecular Biology
- Pharmaceutical Science top 0.5%
- Topics
- Nanoplatforms for cancer theranostics (24 papers)Nanoparticle-Based Drug Delivery (13 papers)Immunotherapy and Immune Responses (9 papers)
In The Last Decade
Ying Hao
57 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 133
- Biomedical Engineering 1.7k
- Biomaterials 769
- Materials Chemistry 739
- Molecular Biology 678
- Pharmaceutical Science 606
Countries citing papers authored by Ying Hao
This map shows the geographic impact of Ying Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Hao more than expected).
Fields of papers citing papers by Ying Hao
This network shows the impact of papers produced by Ying Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Hao. The network helps show where Ying Hao may publish in the future.
Co-authorship network of co-authors of Ying Hao
This figure shows the co-authorship network connecting the top 25 collaborators of Ying Hao. A scholar is included among the top collaborators of Ying Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Hao. Ying Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 6 | |
| 3 | 5 | |
| 4 | 11 | |
| 5 | 15 | |
| 6 | 31 | |
| 7 | 63 | |
| 8 | 13 | |
| 9 | 29 | |
| 10 | 54 | |
| 11 | 41 | |
| 12 | 13 | |
| 13 | 27 | |
| 14 | 69 | |
| 15 | 76 | |
| 16 | 47 | |
| 17 | 11 | |
| 18 | 39 | |
| 19 | 191 | |
| 20 | THE TREND OF ENERGY CONVERSION TECHNOLOGY OF FORESTRY BIOMASS IN CHINA | 1 |
About Ying Hao
Ying Hao is a scholar working on Pharmaceutical Science, Biomaterials and Biomedical Engineering, having authored 57 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (24 papers), Nanoparticle-Based Drug Delivery (13 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Pharmaceutical Science (606 citations), Biomaterials (769 citations) and Biomedical Engineering (1.7k citations). Ying Hao has collaborated with scholars based in China, Singapore and Hong Kong. Frequent co-authors include Zhiyong Qian, Jinrong Peng, Kun Shi, Danrong Hu, Chengli Yang, Xinlong He, Ruxia Han, Yao Xiao, Wei Li and Xingli Zhou. Their work appears in journals such as Biomaterials, Advanced Functional Materials and Journal of Hazardous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.